MCPHARMA BIOTECH INC has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets foods and drinks, pharmaceuticals and macromolecular chemistry and polymers are ASTROGEN CO LTD, BIOHUB CO LTD and SONE FARM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 4 | |
#4 | Australia | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | New Zealand | 2 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Macromolecular chemistry and polymers | |
#4 | Environmental technology | |
#5 | Measurement | |
#6 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Mclaren Derek | 22 |
#2 | Mclaren Earl | 21 |
#3 | Mcclaren Earl | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020243816A1 | Detection, treatment, and monitoring of microbiome-mediated cholesterol homeostasis | |
WO2020056494A1 | Detection, treatment, and monitoring of microbiome-induced metabolic dysfunction | |
US2019256614A1 | Blood Lipids, Glucose Tolerance and Insulin Sensitivity | |
US2019262382A1 | Treatment of colitis with resistant starch | |
AU2017294806A1 | Use of resistant potato starch as a prebiotic to modify microbiota | |
AU2014305623A1 | Improvement of blood lipids, glucose tolerance and insulin sensitivity | |
AU2013312981A1 | Treatment of diarrhea and post-weaning diarrhea with resistant potato starch |